-+ 0.00%
-+ 0.00%
-+ 0.00%

Rezolute’s Phase 3 sunRIZE Trial of Ersodetug in Congenital Hyperinsulinism Misses Primary Endpoint

Reuters·12/11/2025 12:00:46

Please log in to view news